Pharma BD Deal Intelligence
Bayer acquired Merck Consumer Health for $14.2B including Claritin, Coppertone, Dr. Scholl's.
Merck announces sale of its consumer care business to Bayer AG for $14.2 billion. The consumer care business includes leading brands such as Claritin,…
Source summaries from our enrichment pipeline; follow links for originals.
All 4 sources with sentiment breakdown →
Bayer acquired Merck Consumer Health for $14.2B including Claritin, Coppertone, Dr. Scholl's.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Bayer AG / Merck & Co., Inc. (this deal) | 2014 | $14.2B | 71 |
| Bayer AG / Schering AG | 2006 | $21.5B | 79 |
| Bayer AG / BlueRock Therapeutics | 2002 | $600M | 79 |
| Bayer AG / Schering AG (residual squeeze-out) | 2007 | $985M | 69 |
| Bayer AG / Arvinas, Inc. | 2019 | $1.0B | 59 |
| Bayer AG / Merck & Co. Inc. | 2014 | $14.2B | 56 |
| Bayer AG / Asklepios BioPharmaceuticals | 2020 | $2.0B | 49 |
← Browse all deals · How we score deals
More: 2014 deals · Bayer AG deals · Multiple (undisclosed) deals